Piramal Pharma Ltd share price logo

Piramal Pharma Ltd

NSE: PPLPHARMA

BSE: 543635

Small Cap

Pharma Sector

₹171.99

+3.88

(+2.31%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

🔔 Regulatory Approval Alert

Piramal Pharma successfully completes US FDA inspection at Sellersville manufacturing facility; Establishment Inspection Report issued.

Piramal Pharma Stock Performance

as on July 9, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹166.25
    ₹175.95
    downward going graph

    3.34%

    Downside

    2.30%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹132.30
    ₹220.85
    downward going graph

    23.08%

    Downside

    28.41%

    Upside

    downward going graph

Piramal Pharma share price movements today

Previous Close
₹168.11
Open
₹168.10
Volume
78.60L
Upper Circuit
₹201.73
Lower Circuit
₹134.49
Day's Low - High
₹166.25 - ₹175.95
52 Week Low - High
₹132.30 - ₹220.85

Piramal Pharma Historical Returns

1 Month Return
-0.45 %
3 Month Return
+ 17.6 %
1 Year Return
-16.55 %
3 Year Return
+ 88.55 %
5 Year Return
-11.52 %

Piramal Pharma Fundamentals

as on July 9, 2026 at 4:01 pm IST

Market Cap

₹22,381.29 Cr

Return on Equity (ROE)

8.98

PE Ratio (TTM)

-72.02

Return on capital employed (ROCE)

10.77

Industry PE ratio

50.84

Beta (LTM)

0

P/B Ratio

3.99

Dividend Yield

0.06

PEG Ratio

22.79

Quarterly Earnings Growth YOY

-105.75

EPS (TTM)

-2.46

Book Value

61.5

Piramal Pharma Stock Valuation

as on July 9, 2026 at 4:01 pm IST

Piramal Pharma in the last 5 years

  • Overview

  • Trends

Lowest (-1134.06x)

October 29, 2025

Today (-72.02x)

July 6, 2026

Industry (50.84x)

July 6, 2026

Highest (2011.42x)

June 25, 2024

LowHigh

Today’s Price to Earnings Ratio: -72.02x

Piramal Pharma Technical Analysis

Track how Piramal Pharma technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish1
Bullish11
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
0.03
Bullish
CCI (20)
-264.9
Bullish
RSI (14)
51.69
Neutral
Momentum (10)
-0.02
Bearish
ADI (14)
19.5
Neutral
Ultimate Oscillator (7,14,28)
61.1
Neutral

Moving Averages

Name

Value

Action

SMA (20)
172.02
Bullish
EMA (20)
172.03
Bullish
VWMA (20)
172.05
Bullish
SMA (50)
171.99
Bullish
EMA (50)
172.02
Bullish
SMA (200)
172.01
Bullish
EMA (200)
172.07
Bullish
KAMA (200)
172.03
Bullish
DEMA (200)
172
Bullish

Piramal Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Piramal Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Piramal Pharma Ltd image
Piramal Pharma Ltd
BUY22,381.29-2.3%0.69-3268,869
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
HOLD16,480.99-1.74%0.682641,197
Jubilant Pharmova Ltd image
Jubilant Pharmova Ltd
BUY15,464.056.58%0.008367,234
Sun Pharma Advanced Research Company Ltd image
Sun Pharma Advanced Research Company Ltd
BUY8,761.431.78%1.88-34371
Rainbow Childrens Medicare Ltd image
Rainbow Childrens Medicare Ltd
BUY14,535.2043.58%0.672811,703
See all

Market expectation of Piramal Pharma Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Piramal Pharma Stock’s Investor Sentiment and Interest

Investment in Piramal Pharma Ltd Shares on INDmoney has grown by 583.33% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:583.33% versus previous 30 day period

Search interest for Piramal Pharma Ltd Stock has increased by 132% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:132% versus previous 30 day period

Piramal Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Sales
1,911.38
1,958.57
2,552.36
1,951.14
2,241.75
2,204.22
2,754.07
1,933.71
2,043.72
2,139.87
2,751.77
Other Income
68.3
75.46
38.42
41.94
78.37
29.18
58.25
97.71
80.39
53.5
59.63
Total Income
1,979.68
2,034.03
2,590.78
1,993.08
2,320.12
2,233.4
2,812.32
2,031.42
2,124.11
2,193.37
2,811.4
Expenses
1,645.74
1,722.47
2,052.95
1,746.65
1,900.14
1,866.48
2,193.08
1,827.01
1,885.03
1,985.25
2,467.03
Operating Profit
265.64
236.1
499.41
204.49
341.61
337.74
560.99
106.7
158.69
154.62
284.74
Operating Profit Margin %
13.9%
12.05%
19.57%
10.48%
15.24%
15.32%
20.37%
5.52%
7.76%
7.23%
10.35%
Profit Before Interest, Tax and Depreciation
333.94
311.56
537.83
246.43
419.98
366.92
619.24
204.41
239.08
208.12
344.37
Interest
109.87
105.88
114.22
106.96
107.64
103.31
103.68
86.15
82.42
89.24
82.99
Depreciation
184.51
186.32
196.13
184.55
192.22
196.81
242.76
197.28
202.84
212.74
218.38
Profit Before Tax
39.56
19.36
227.48
-45.08
120.12
66.8
272.8
-79.02
-46.18
-93.86
43
Tax Paid
34.54
9.25
126.21
43.56
97.53
63.12
119.3
2.68
53.04
42.33
51.83
Profit After Tax
5.02
10.11
101.27
-88.64
22.59
3.68
153.5
-81.7
-99.22
-136.19
-8.83
Total Net profit including share of profit / Loss from associate company
5.02
10.11
101.27
-88.64
22.59
3.68
153.5
-81.7
-99.22
-136.19
-8.83
EPS
0.04
0.08
0.77
-0.67
0.17
0.03
1.16
-0.62
-0.75
-1.03
-0.07
Actual EPS
0.04
0.08
0.77
-0.67
0.17
0.03
1.16
-0.62
-0.75
-1.03
-0.07
Adjusted EPS
0.04
0.08
0.77
-0.67
0.17
0.03
1.16
-0.62
-0.75
-1.03
-0.07
Diluted EPS
0.04
0.08
0.77
-0.67
0.17
0.03
1.16
-0.62
-0.75
-1.03
-0.07

Piramal Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
6,559.1
7,081.55
8,171.16
9,151.18
8,869.08
Other Income
334.83
279.44
234.88
207.74
270.5
Total Income
6,893.93
7,360.99
8,406.04
9,358.92
9,139.58
Expenses
5,624.52
6,460.27
7,037.69
7,706.35
8,143.6
Operating Profit
934.58
621.28
1,133.47
1,444.83
725.48
Operating Profit Margin %
14.25%
8.77%
13.87%
15.79%
8.18%
Profit Before Interest, Tax and Depreciation
1,269.41
900.72
1,368.35
1,652.57
995.98
Interest
198.25
344.18
448.49
421.59
340.8
Depreciation
586.18
676.69
740.57
816.34
831.24
Profit Before Tax
484.98
-120.15
179.29
414.64
-176.06
Tax Paid
109.02
66.31
161.47
323.51
149.88
Profit After Tax
375.96
-186.46
17.82
91.13
-325.94
Total Net profit including share of profit / Loss from associate company
375.96
-186.46
17.82
91.13
-325.94
EPS
3.19
-1.57
0.14
0.69
-2.46
Actual EPS
3.19
-1.57
0.14
0.69
-2.46
Adjusted EPS
3.12
-1.53
0.14
0.69
-2.46
Diluted EPS
3.19
-1.57
0.14
0.68
-2.46

Piramal Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
597.58
766.42
483.89
1,004.54
892.3
1,652.6
Cash Flow from Investing Activities
-4,464.39
-1,737.4
-1,333.63
-416.22
-488.34
-819.68
Cash Flow from Financing Activities
3,976.83
794.19
817.79
-422.36
-440.83
-38.98
Net Cash Flow
110.02
-176.79
-31.95
165.96
-36.87
793.94

Piramal Pharma Stock Shareholding Pattern

Numbers in percentages

Aug 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Promoters
35.02%
35.02%
35.02%
35.02%
34.95%
34.95%
34.95%
34.95%
34.86%
34.86%
34.86%
34.86%
DII
7.83%
8.02%
9.68%
12.12%
12.95%
13.81%
14.1%
14.78%
14.26%
14.89%
15.69%
15.61%
FII
18.04%
32.37%
32.51%
30.59%
31.42%
31.73%
31.68%
31.49%
30.86%
30.27%
29.66%
30.18%
Public
24.54%
24.21%
22.41%
21.89%
20.21%
19.07%
18.87%
18.44%
19.45%
19.47%
19.35%
19.01%
Total Outstanding Shares
1,32,29,23,098
1,32,29,48,130
1,32,29,48,130
1,32,29,48,130
1,32,57,48,130
1,32,57,48,130
1,32,57,48,130
1,32,57,48,130
1,32,92,48,130
1,32,92,48,130
1,32,92,48,130
1,32,92,48,130
Total Shareholders
2,95,773
3,00,606
2,92,312
2,97,996
3,06,398
3,59,751
4,18,442
4,32,843
4,58,430
4,62,511
4,53,830
4,50,661

Mutual Funds that own Piramal Pharma Stock

Check out the Mutual Funds with significant holdings in Piramal Pharma.

Piramal Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Piramal Pharma.

  • Piramal Pharma Ltd Earnings Results

    Piramal Pharma Ltd’s net profit fell -105.75% since last year same period to ₹-8.83Cr in the Q4 2025-2026. On a quarterly growth basis, Piramal Pharma Ltd has generated 93.52% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Piramal Pharma Ltd Dividends May,2025

    In the quarter ending March 2025, Piramal Pharma Ltd has declared dividend of ₹0.14 per share on 14 May 2025 - translating a dividend yield of 0.08%.

    Read More about Dividends

Piramal Pharma News & Key Events

  • img

    Today's Timeline - 09 July

    11:04 AM

    -

    Piramal Pharma receives US FDA's Establishment Inspection Report, successfully closing the inspection of its Sellersville facility.

Indices Featuring Piramal Pharma Stock

Check stock indices that include Piramal Pharma.

Nifty Small 100

₹19,120.85

337.55 (▲1.80%)

Nifty MidSmallcap 400

₹21,044.95

304.50 (▲1.47%)

Nifty Smallcap 250

₹17,875.70

277.80 (▲1.58%)

S&P BSE 400 MidSmallCap

₹12,551.02

186.41 (▲1.51%)

Nifty Healthcare

₹16,307.25

161.50 (▲1.00%)

Nifty 500

₹23,081.15

173.10 (▲0.76%)

NIFTY PHARMA

₹25,656.25

226.45 (▲0.89%)

S&P BSE SmallCap Select

₹8,687.15

153.10 (▲1.79%)

BSE 500

₹36,086.55

265.11 (▲0.74%)

S&P BSE 250 SmallCap

₹7,068.66

117.80 (▲1.69%)

Nifty Smallcap 50

₹9,477.95

171.10 (▲1.84%)

BSE Healthcare

₹49,798.76

592.15 (▲1.20%)

Insights on Piramal Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -136.19 Cr → -8.83 Cr (in ₹), with an average increase of 1442.4% per quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 14.03% to 14.12% in Mar 2026 quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 11.71% to 12.22% in Mar 2026 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 2.03K Cr → 2.81K Cr (in ₹), with an average increase of 9.8% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, PPLPHARMA stock has moved up by 17.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 45.1% return, outperforming this stock by 61.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 154.5% return, outperforming this stock by 66.0%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 34.86% of holdings in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 19.35% to 19.01% in Mar 2026 quarter

About Piramal Pharma Ltd

Piramal Pharma Limited is an integrated company offering products and services through manufacturing capabilities and global distribution. The business is divided into three main parts - CDMO CHG and ICH - and offers services such as drug discovery, clinical development and active pharmaceutical ingredient commercialisation. Through its 15 global manufacturing facilities and a global distribution network in over 100 countries, the company offers a range of self-care products and unique capabilities in areas such as antibody drug conjugates and biologics. The company has achieved multiple milestones in 2020 and 2021, such as acquiring the pharmaceutical business from Piramal Enterprises Limited, receiving growth equity investment from The Carlyle Group, and expanding its capabilities in Grangemouth and Riverview. In 2022, Piramal Pharma Limited acquired a minority stake in Yapan Bio Private Limited. Overall, the company is experienced in providing global delivery capabilities for its customers and has a diversified manufacturing footprint allowing for market proximity and cost efficient production.

Revenue: ₹2,751.77Cr as on March 2026 (Q4 FY26)
Net Profit: ₹-8.83Cr as on March 2026 (Q4 FY26)
Listing date: 19 Oct, 2022
Chairperson Name: Nandini Piramal
OrganisationPiramal Pharma Ltd
IndustryPharmaceuticals
CEONandini Piramal
E-voting on sharesClick here to vote

FAQs

What is Piramal Pharma share price today?

Piramal Pharma share price today stands at ₹171.99 as on at the close of the market. Piramal Pharma share today touched a day high of ₹175.95 and a low of ₹166.25.

What is the 52 week high and 52 week low range for Piramal Pharma share?

Piramal Pharma touched a 52 week high of ₹220.85 and a 52 week low of ₹132.3. Piramal Pharma share price today i.e. is closed at ₹171.99, which is -22.12% down from its 52 week high and 30.00% up from its 52 week low.

What is Piramal Pharma's market capitalisation today?

Piramal Pharma market capitalisation is ₹22,381.29 Cr as on .

How to buy Piramal Pharma shares?

To buy Piramal Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for PPLPHARMA or Piramal Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Piramal Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Piramal Pharma trading volume today?

Piramal Pharma trading volume is 78.60L as on . This means that 78.60L shares of Piramal Pharma were bought and sold on the stock market during today's trading session.